Ask VialBase
weight · loss

5-Amino-1MQ

FDA: research-only

5-Amino-1MQ is a small molecule NNMT inhibitor that preserves and boosts NAD+ levels, leading to more efficient mitochondrial energy production and fat oxidation. It targets metabolic sluggishness at the enzymatic level, making the body burn more calories at rest. Inhibits NNMT (nicotinamide N-methyltransferase), an enzyme often overactive in people with obesity, metabolic disorders, or aging-related fatigue. When NNMT is overactive it drains NAD+ building blocks. By blocking NNMT, 5-Amino-1MQ preserves NAD+ availability, activates energy-generating pathways including fat oxidation and glucose metabolism, and stimulates mitochondrial biogenesis (PMID: 39604638). - Preserves and boosts NAD+ levels for more efficient mitochondrial energy production -

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —

Stacks containing 5-Amino-1MQ

Mito-Melt

MOTS-c + 5-Amino-1MQ + GHK-Cu (optional)

Shred

AOD-9604 + MOTS-c + 5-Amino-1MQ

28-day resets featuring 5-Amino-1MQ

02

Sourcing

Current prices

Updated today

10mg

50mg

Only vendor stocking this size on the VialBase roster.

Size unspecified

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 20% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs Positive rep

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

Also vetted at
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Lipid Panel
  • Fasting Glucose
  • Fasting Insulin
DURING CYCLE
  • CMP
  • Fasting Glucose
POST-CYCLE
  • CMP
  • Lipid Panel
  • Fasting Glucose
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for 5-Amino-1MQ may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule NNMT inhibitor that preserves and boosts NAD+ levels, leading to more efficient mitochondrial energy production and fat oxidation.
How does 5-Amino-1MQ work?
Inhibits NNMT (nicotinamide N-methyltransferase), an en.
How is 5-Amino-1MQ dosed?
Oral: 10-20 mg/day (most common biohacker dose); 50-100 mg/day in some research protocols; Cycle: 4-6 weeks on; Route: Oral. These figures reflect commonly cited research protocols, not medical advice — consult a clinician.
Is 5-Amino-1MQ FDA-approved?
5-Amino-1MQ is a research-only compound and is not FDA-approved. Research-only compound — not FDA-approved for human use; Available through research chemical suppliers; Not yet in clinical trials for general metabolic use.